PRPF18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.33146835171283E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.15000239833785E-11 |
Normal-vs-Stage2 |
2.56080000005099E-06 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
9.70412639134111E-12 |
Stage1-vs-Stage2 |
6.852400E-01 |
Stage1-vs-Stage3 |
4.3188999999999E-05 |
Stage1-vs-Stage4 |
1.794010E-02 |
Stage2-vs-Stage3 |
5.036400E-02 |
Stage2-vs-Stage4 |
2.465200E-01 |
Stage3-vs-Stage4 |
3.171200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62825308791525E-12 |
Normal-vs-AfricanAmerican |
7.81040000452649E-08 |
Normal-vs-Asian |
7.644500E-03 |
Caucasian-vs-AfricanAmerican |
6.718800E-01 |
Caucasian-vs-Asian |
8.143200E-01 |
AfricanAmerican-vs-Asian |
9.498000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.22044604925031E-16 |
Normal-vs-Female |
3.52869955477786E-10 |
Male-vs-Female |
8.579300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.55949999872618E-08 |
Normal-vs-Age(41-60Yrs) |
1.82630022216301E-10 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
2.007599999998E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.919170E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.546000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.091800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030040E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.660200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.152400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.593000E-01 |
Normal-vs-Grade 2 |
3.77550002372828E-09 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.63624669369256E-12 |
Grade 1-vs-Grade 2 |
2.031900E-02 |
Grade 1-vs-Grade 3 |
7.52529999999973E-05 |
Grade 1-vs-Grade 4 |
8.22420000000657E-05 |
Grade 2-vs-Grade 3 |
1.238560E-04 |
Grade 2-vs-Grade 4 |
1.58473999999353E-05 |
Grade 3-vs-Grade 4 |
5.033500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.75239999955501E-07 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
8.93199958440505E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.37539979405688E-11 |
Normal-vs-N1 |
1.65838999999224E-05 |
N0-vs-N1 |
3.865600E-01 |
|
|